II
GMAB icon

Inspire Investing’s Genmab GMAB Stock Holding History

Inspire Investing’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
1
– – ﹤0.01% 1252
2026
Q1 		$24 Hold
1
– – ﹤0.01% 1094
2025
Q4 		$25 Buy
+1
New +$31 ﹤0.01% 1097
2021
Q2 		– Sell
-16,280
Closed -$534K – 602
2021
Q1 		$534K Buy
16,280
+7,495
+85% +$282K 0.08% 270
2020
Q4 		$357K Buy
+8,785
New +$328K 0.08% 352

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Inspire Investing's GMAB Position: Q2 2026 in Review

Inspire Investing held its Genmab (GMAB) position steady in Q2 2026 at 1 share worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Inspire Investing first reported a position in GMAB in Q4 2020 and has held it in 5 quarters since. The position peaked at $534K in Q1 2021. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Inspire Investing held 1 share of Genmab worth $25 as of Q2 2026.
  • Inspire Investing left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1252 holding.
  • Inspire Investing first reported a position in Genmab in Q4 2020 and has held it in 5 quarters since.
  • Inspire Investing's Genmab position peaked at $534K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.